Silexion Therapeutics (SLXN) Q1 2025 Earnings

18MarConfirmed
Q1 1
Q3 2024
Q4 2024
Q1 2025
-7.4
-4.97
-2.54
-0.11

Details

Expected EPS
-0.98
Actual EPS
-0.77
Surprise EPS
0.21
Surprise Percent
+21.43%

Description

Silexion Therapeutics (SLXN) has reported earnings of -0.77 per share for Q1 2025.

0 Comments

Share your thoughts